On Fri, 21 Feb 1997 18:42:30 -0500 "Brian C.Black" <[log in to unmask]>
writes:
>>My father has recently been requested to participate in a study of a
>new drug
>>called Tasmar, aka- Tolcapone. Has anyone else been approached to
>participate
>>in this study or know anything about this drug? My dad has not
>responded to
>>any other medications- including Sinemet- maybe that is why they
>chose him,
>>but the letter indicates differently. I am just looking for anyone
>else that
>>is considering participating in the study. Please email me at
>>[log in to unmask] or respond on the listserv for eveyones' benifit.
>Thank you
>>for your time.
>Hi Gail:
>I have been involved with the Canadian study of Tolcapone for more
>than two
>months. I'm on the last stage, and for me it has been great . It is
>designed for people who have "end of dose drop off", and it has
>allowed me
>to reduce my pill-taking times to three a day from four. This has
>made a
>big difference in my life. I can now enjoy almost an entire day of
>"ons".
>However, it is not for everyone; there have been a few minor problems.
> If
>you need more data, let me know.
>All the Best, Brian Black
>
Brian,
I have "end-of-dose-drop-off." I'm sure many of us do. Is there
someone on our list who can help me to know more about Tolcapone?
Especially, I want to understand how it is supposed to work at the
chemical and cellular level.
I need medications every 3 hours around the clock (8 x per day).
Thanks a million,
Ivan Suzman, Portland, Maine 47/10 40 deg. F> raining and almost
springlike
